Quiz Ref ID Patients with hematologic malignancies hospitalized for hematopoietic stem cell transplantation (HCT) experience physical symptoms due to chemotherapy-induced toxic effects and early posttransplantation complications.
1-4 These symptoms, along with the physical isolation patients experience during the 3- to 4-week hospitalization, can contribute to a decline in their quality of life (QOL) and mood throughout their hospital stay.
4-6 Furthermore, the distress patients experience during transplantation often persists and has long-term QOL and psychological consequences, further exacerbating the morbidity of HCT.
2,5,7 Despite the physical and psychological burden experienced by patients undergoing HCT, studies of interventions to improve their QOL and reduce their distress during HCT are limited.
1,4,8-10 Clinicians often perceive patients’ physical and psychological symptoms during transplantation to be expected and unmodifiable.
4,11 Although palliative care clinicians are increasingly asked to care for patients with solid tumors, they are infrequently consulted for patients with hematologic malignancies.
12-14